$0.56
-0.06 (-9.62%)
Open$0.61
Previous Close$0.62
Day High$0.63
Day Low$0.54
52W High$4.93
52W Low$0.30
Volume—
Avg Volume403.4K
Market Cap7.65M
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.13M | 8.77M | 1.76M |
| Net Income | -245,246,238 | -191,084,420 | -56,960 |
| Profit Margin | -2,421.8% | -2,300.7% | -3.2% |
| EBITDA | -221,635,319 | -182,281,666 | -70,729 |
| Free Cash Flow | — | — | -37,098 |
| Rev Growth | +15.5% | +15.5% | +11.5% |
| Debt/Equity | 0.37 | 0.37 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |